Yu Zhang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Randomized Controlled Trial

Top Venues

Open forum infectious diseases

Cancer research

Journal of oncology

Journal of gynecologic oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaohua Wu, Jihong Liu, Ruifang An, Rutie Yin, Yu Zhang, Huaijun Zhou, Aiqin He, Li Wang, Jieqing Zhang, Ziling Liu, Wei Duan, Jian Qing Zhu, Ge Lou, Guilin Chen, Ying Cheng, Fengxia Xue, Sonja Nick, Haiyan Wang, Donghang Li
First-line bevacizumab plus chemotherapy in Chinese patients with stage III/IV epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer: a phase III randomized controlled trial. Journal of gynecologic oncology (2024)
Fang Zhu, Siyu Yang, Ming Lei, Qiongqiong He, Lisha Wu, Yu Zhang
DNA Repair Protein HELQ and XAB2 as Chemoresponse and Prognosis Biomarkers in Ascites Tumor Cells of High-Grade Serous Ovarian Cancer. Journal of oncology 2022 (2022)
Kun Fu, Ming Lei, Li-Sha Wu, Jing-Cheng Shi, Si-Yu Yang, Wen-Qing Yang, Jin-Yun Xu, Ya-Nan Kang, Zhen-Ying Yang, Xuan Zhang, Kang-Ni Huang, Chi Han, Yan Tian, Yu Zhang
Triage by PAX1 and ZNF582 Methylation in Women With Cervical Intraepithelial Neoplasia Grade 3: A Multicenter Case-Control Study. Open forum infectious diseases 9 (5) (2022)
Xufeng Lu, Dazhuan E Xin, Juanjuan K Du, Quanli C Zou, Qian Wu, Yanan S Zhang, Wenhai Deng, Jicheng Yue, Xing S Fan, Yuanyuan Zeng, Xiaju Cheng, Xue S Li, Zhaoyuan Hou, Man Mohan, Ting C Zhao, Xiaomei Lu, Zhijie Chang, Li-Yan Xu, Yu Sun, Xiongbing Zu, Yu Zhang, Y Eugene Chinn
Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression. Cancer research 82 (23) (2022)